title: [Latest advances in chronic pancreatitis].
abstract: This article summarizes some of the recent and clinically relevant advances in chronic pancreatitis. These advances mainly concern knowledge of the etiopathogenesis of the disease, the pharmacological treatment of pain, and knowledge of the natural history of autoimmune pancreatitis. New evidence supports the relatively low prevalence of chronic alcoholic pancreatitis, and the role of tobacco in triggering the etiopathogenic mechanisms of chronic pancreatitis is better understood. Some studies have identified certain factors that are associated with having a positive genetic test in adults with chronic idiopathic pancreatitis, which should help to select those patients who should undergo genetic studies. Antioxidant therapy has been shown to be effective in reducing pain secondary to chronic pancreatitis, although the type and optimal dose of antioxidants remains to be elucidated. Finally, the development of exocrine and endocrine pancreatic insufficiency is a very common finding during the long-term follow-up of patients with autoimmune pancreatitis. Smoking also seems to play a role in this type of pancreatitis.
authors.affiliation: Servicio de Aparato Digestivo, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, España. Electronic address: enriquedominguezmunoz@hotmail.com.
authors.forename: J Enrique
authors.initials: JE
authors.lastname: Domínguez-Muñoz
mesh_terms: D006801:Humans; D050500:Pancreatitis, Chronic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
keywords: Antioxidantes; Antioxidants; Autoimmune pancreatitis; Chronic pancreatitis; Exocrine pancreatic insufficiency; Insuficiencia pancreática exocrina; Pancreatitis autoinmune; Pancreatitis crónica